J&J's MedTech Segment Eyes Another Strong Quarter in Q2
Johnson & Johnson's JNJ MedTech division, which includes orthopedics, surgery, cardiovascular, electrophysiology, vision and wound closure products, contributes roughly 36% to the company’s total revenues.J&J is repositioning its MedTech portfolio toward more innovative, faster-growing areas, most…